PharmAzzy

Zonhoven ·KBO/BCE: BE 0784.514.521

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	08-06-2026	53 d early	2026-00143664
31-12-2024	31-07-2025	14-07-2025	17 d early	2025-00265197
31-12-2023	31-07-2024	26-06-2024	35 d early	2024-00163056
31-12-2022	31-07-2023	08-06-2023	53 d early	2023-00115584

Metric	This company	Sector median	Position in the sector
Solvency	67.3%	23.8%	better than 82% of 1408 sector peers
Net result	€19k	€8k	better than 65% of 1405 sector peers
Equity	€25k	€26k	better than 49% of 1409 sector peers
Gross operating margin	€16k	€36k	better than 33% of 1402 sector peers
Total assets	€38k	€133k	better than 19% of 1409 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€38k
Fixed assets	21/28	€16k
Tangible fixed assets	22/27	€16k
Current assets	29/58	€22k
Amounts receivable within one year	40/41	€20k
Cash & bank	54/58	€89
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€38k
Equity	10/15	€25k
Contributions / capital	10/11	€3k
Reserves	13	€23k
Accumulated profits (losses)	14	€-324
Amounts payable	17/49	€12k
Amounts payable within one year	42/48	€11k
Trade debts payable within one year	44	€5k
Income statement
Gross operating margin	9900	€16k
Operating result	9901	€11k
Financial income	75	€607
Financial charges	65	€324
Result before taxes	9903	€21k
Income taxes	67/77	€2k
Net result for the period	9904	€19k
Result to be appropriated	9905	€19k

Summary